These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 24830593)

  • 1. An overview on the treatment of postmenopausal osteoporosis.
    Maeda SS; Lazaretti-Castro M
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):162-71. PubMed ID: 24830593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing osteoporosis-related fractures: an overview.
    Gass M; Dawson-Hughes B
    Am J Med; 2006 Apr; 119(4 Suppl 1):S3-S11. PubMed ID: 16563939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.
    Reginster JY
    Drugs; 2011 Jan; 71(1):65-78. PubMed ID: 21175240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis.
    Barrionuevo P; Kapoor E; Asi N; Alahdab F; Mohammed K; Benkhadra K; Almasri J; Farah W; Sarigianni M; Muthusamy K; Al Nofal A; Haydour Q; Wang Z; Murad MH
    J Clin Endocrinol Metab; 2019 May; 104(5):1623-1630. PubMed ID: 30907957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.
    Lewiecki EM
    J Womens Health (Larchmt); 2009 Oct; 18(10):1615-26. PubMed ID: 19857095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for the prevention and treatment of osteoporosis during early postmenopause.
    Delaney MF
    Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S12-23. PubMed ID: 16448872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
    Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
    Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to manage postmenopausal osteoporosis?
    Body JJ
    Acta Clin Belg; 2011; 66(6):443-7. PubMed ID: 22338309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and prevention of osteoporosis.
    Blahos J
    Wien Med Wochenschr; 2007; 157(23-24):589-92. PubMed ID: 18204959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
    Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
    Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal osteoporosis: Assessment and management.
    Rizzoli R
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):739-757. PubMed ID: 30449552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developments in the pharmacotherapeutic management of osteoporosis.
    Close P; Neuprez A; Reginster JY
    Expert Opin Pharmacother; 2006 Aug; 7(12):1603-15. PubMed ID: 16872263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I;
    Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on osteoporosis therapy.
    Borges JL; Bilezikian JP
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):755-63. PubMed ID: 17117300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
    Epstein S
    Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update on treatment of postmenopausal osteoporosis].
    Body JJ
    Rev Med Brux; 2008 Sep; 29(4):301-9. PubMed ID: 18949981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?
    Miller PD; Derman RJ
    Osteoporos Int; 2010 Nov; 21(11):1793-802. PubMed ID: 20309524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.